CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 237 SEK -0.84%
Market Cap: 5.7B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Operating Income Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Operating Income
kr183.8m
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
15%
Elekta AB (publ)
STO:EKTA B
Operating Income
kr2.4B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Operating Income
kr147.8m
CAGR 3-Years
82%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Operating Income
kr4.1B
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Operating Income
kr968m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Operating Income
kr61.9m
CAGR 3-Years
45%
CAGR 5-Years
20%
CAGR 10-Years
40%

See Also

What is CellaVision AB's Operating Income?
Operating Income
183.8m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Operating Income amounts to 183.8m SEK.

What is CellaVision AB's Operating Income growth rate?
Operating Income CAGR 10Y
15%

Over the last year, the Operating Income growth was 44%. The average annual Operating Income growth rates for CellaVision AB have been 14% over the past three years , 7% over the past five years , and 15% over the past ten years .

Back to Top